4//SEC Filing
Cramer Pamela J. 4
Accession 0001104659-25-071849
CIK 0001649904other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 6:56 PM ET
Size
9.1 KB
Accession
0001104659-25-071849
Insider Transaction Report
Form 4
Cramer Pamela J.
Chief Human Resources Officer
Transactions
- Sale
Common Stock
2025-07-29$85.93/sh−1,520$130,614→ 20,814 total - Exercise/Conversion
Common Stock
2025-07-26+3,125→ 22,334 total - Exercise/Conversion
Restricted Stock Units
2025-07-26−3,125→ 0 total→ Common Stock (3,125 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- [F3]The restricted stock units vest as to 25% of the total shares on each of July 26, 2022, July 26, 2023, July 26, 2024 and July 26, 2025. The restricted stock units have no expiration date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001873517
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 6:56 PM ET
- Size
- 9.1 KB